Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Bayer

US Top Court To Decide On Bayer's Roundup Weedkiller Appeal

The U.S. Supreme Court will likely reveal its decision over offering a clean chit to Bayer A.G.'s (OTC:BAYZF) Roundup weedkiller, Reuters reports. Bayer sought the review of an appeals court that sustained $25 million in damages awarded to a user of glyphosate-based weedkiller Roundup, who blamed his cancer on the product. Bayer urged…

Benzinga

U.S. Supreme Court will soon decide whether to hear Bayer's weedkiller case

The U.S. Supreme Court could announce as soon as Monday whether it will hear Bayer's bid to dismiss claims its Roundup weedkiller causes cancer as the company seeks to avoid potentially billions of dollars more in damages and payouts.

Reuters

EU regulators ‘dismissed evidence’ linking glyphosate to rodent tumours

European Chemical Agency’s positive assessment for continued sale of substance is flawed, say environmental campaigners

The Guardian - UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Arsenal miss out on Mikel Arteta striker target as familiar problem emerges

Mikel Arteta's Arsenal are looking to sign at least one new centre-forward this summer after missing out on Champions League qualification to bitter rivals Tottenham

Daily Mirror

The Daily Biotech Pulse: CDC Recommends COVID-19 Boosters For Kids 5-11, Foghorn's Blood Cancer Trial On Clinical Hold, Bayer Intends To Bow Out From CAR-T Therapy Pact With Atara

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

Considering an IUD but worried about pain during insertion? Here’s what to expect

Intrauterine devices (IUDs) are small T-shaped plastic devices containing either copper or a low dose of progestogen hormone. Lasting five to ten years, they provide highly effective contraception and are chosen by increasing numbers of users of all ages from adolescence to perimenopause.

The Conversation

Post-pandemic healthcare

Health crises and emergencies such as Covid-19 have brought into sharp focus the critical need for preparedness. The unprecedented pandemic has led to a dynamically changing environment across the healthcare industry, posing challenges that call for innovative solutions.

Bangkok Post

Read news from The Economist, FT, and more,
with one subscription

Medical societies and health-care companies may be too close for comfort

There are three different types of organizations for doctors in Canada: ones that license doctors to be able to practise and ensure that they are competent; ones that develop programs to train family doctors and specialists; and medical societies.

The Conversation

Why wealthy countries and companies need to do more to clean up global toxic chemical pollution

Keeping the environment safe is a shared responsibility between nations. But when it comes to harmful substances, especially persistent organic pollutants, advanced industrial nations should put more effort into reducing their global impacts.

The Conversation

Will we soon be able to ‘fix’ periods?

For many, menstruation involves pain, fatigue, mood swings and worse, yet there have been no new treatments for 30 years. Now science promises breakthroughs

The Guardian - UK

Saving Egyptian Pumpkins Is Key For Biodiversity And Future Farmers, Scientists Say

Non-native cultivars of squash could crowd out native squashes already adapted to Egyptian growing conditions and practices.

Zenger

Pfizer, Bayer to maintain drug supply to Russia

Pfizer Inc and Bayer said on Monday they would maintain humanitarian supply of medicines to Russia, but would pull back from other non-essential spending in the country.

Reuters

Recap: Bayer Q4 Earnings

Bayer (OTC:BAYRY) reported its Q4 earnings results on Tuesday, March 1, 2022 at 01:30 AM. Here's what investors need to know about the announcement. Earnings Bayer beat estimated earnings by 33.33%, reporting an EPS of $0.36 versus an estimate of $0.27.

Benzinga

Bayer glyphosate, Roundup production takes a hit, but Australian farmers may have 'dodged a bullet'

As farmers prepare for new crops, the company that makes high-demand glyphosate products, including Roundup, details a major issue.

ABC News

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Why Are Evotec Shares Trading Lower On Friday?

Bayer AG (OTC: BAYRY) has

Motorsport

FIA admits that Masi's F1 job could be under threat

Senior FIA official Peter Bayer has admitted that Formula 1 race director Michael Masi could be replaced.

1 … 7 8 9 10

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Arsenal

57,971 stories

UEFA Champions League

Environmental Protection Agency

203 stories

Monsanto

83 stories

European Medicines Agency

76 stories

Roche

67 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.